Evidence map›Paper›PMID 33755307›Full record

ArticleMicrobial biotechnology2022

Can it be all more simple? Manufacturing aflatoxin biocontrol products using dry spores of atoxigenic isolates of Aspergillus flavus as active ingredients.

Alejandro Ortega-Beltran, Lawrence Kaptoge, Amadou L Senghor, Morounranti O S Aikore, Patrick Jarju, Henry Momanyi, Matieyedou Konlambigue, Titilayo D O Falade, Ranajit Bandyopadhyay

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Alejandro Ortega-BeltranInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
Lawrence KaptogeInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
Amadou L SenghorIITA, Dakar, Senegal.
Morounranti O S AikoreInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
Patrick JarjuNational Food Security, Processing and Marketing Corporation, Banjul, The Gambia.
Henry MomanyiIITA, Nairobi, Kenya.
Matieyedou KonlambigueIITA, Accra, Ghana.
Titilayo D O FaladeInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
Ranajit BandyopadhyayInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.ORCID 0000-0003-2422-4298
International Institute of Tropical Agriculture · NGEdward Francis Small Teaching Hospital · GMInstitut International des Sciences et de Technologie · SNInternational Institute of Tropical Agriculture · NGInternational Institute of Tropical Agriculture · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aflatoxin contamination of staple crops, commonly occurring in warm areas, negatively impacts human and animal health, and hampers trade and economic development. The fungus Aspergillus flavus is the major aflatoxin producer. However, not all A. flavus genotypes produce aflatoxins. Effective aflatoxin control is achieved using biocontrol products containing spores of atoxigenic A. flavus. In Africa, various biocontrol products under the tradename Aflasafe are available. Private and public sector licensees manufacture Aflasafe using spores freshly produced in laboratories adjacent to their factories. BAMTAARE, the licensee in Senegal, had difficulties to obtain laboratory equipment during its first year of production. To overcome this, a process was developed in Ibadan, Nigeria, for producing high-quality dry spores. Viability and stability of the dry spores were tested and conformed to set standards. In 2019, BAMTAARE manufactured Aflasafe SN01 using dry spores produced in Ibadan and sent via courier and 19 000 ha of groundnut and maize in Senegal and The Gambia were treated. Biocontrol manufactured with dry spores was as effective as biocontrol manufactured with freshly produced spores. Treated crops contained safe and significantly (P < 0.05) less aflatoxin than untreated crops. The dry spore innovation will make biocontrol manufacturing cost-efficient in several African countries.

Indexed as

AflatoxinsAnimalsAspergillus flavusCrops, AgriculturalNigeriaSpores, FungalZea maysAflatoxins

Identifiers

PMID33755307
PMCPMC8913866
OpenAlexW3136409059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.